AstraZeneca PLC Cash Flow Reinvestment Rate
AstraZeneca PLC cash flow reinvestment rate. AstraZeneca PLC (AZN) has a Cash Flow Reinvestment Rate of 0.49x as of March 2026, reinvesting $1.63 Billion (capex $1.54 Billion plus investments $-93.00 Million) from operating cash flow of $3.36 Billion. See AZN financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of AstraZeneca PLC (1990–2025)
Cash flow reinvestment rate of AstraZeneca PLC from 1990 to 2025. Historical reinvestment intensity for AstraZeneca PLC across 36 annual periods. Explore AZN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
AstraZeneca PLC Cash Flow Reinvestment Rate by Year (1990–2025)
AstraZeneca PLC cash flow reinvestment rate by year from 1990 to 2025. Year-by-year capital reinvestment analysis for AstraZeneca PLC. For the full cash flow conversion analysis, see how efficiently does AstraZeneca PLC generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | $2.91 Billion | $14.57 Billion | $2.81 Billion | ▼ -48.5% |
| 2024 | 0.39x | $4.60 Billion | $11.86 Billion | $4.59 Billion | ▲ +6.0% |
| 2023 | 0.37x | $3.79 Billion | $10.35 Billion | $3.78 Billion | ▲ +33.5% |
| 2022 | 0.27x | $2.69 Billion | $9.81 Billion | $2.57 Billion | ▼ -28.3% |
| 2021 | 0.38x | $2.28 Billion | $5.96 Billion | $2.20 Billion | ▼ -29.6% |
| 2020 | 0.54x | $2.61 Billion | $4.80 Billion | $2.61 Billion | ▼ -34.5% |
| 2019 | 0.83x | $2.46 Billion | $2.97 Billion | $2.46 Billion | ▲ +58.2% |
| 2018 | 0.52x | $1.37 Billion | $2.62 Billion | $1.37 Billion | ▲ +15.7% |
| 2017 | 0.45x | $1.62 Billion | $3.58 Billion | $1.62 Billion | ▼ -18.9% |
| 2016 | 0.56x | $2.31 Billion | $4.14 Billion | $2.31 Billion | ▼ -33.4% |
| 2015 | 0.84x | $2.79 Billion | $3.32 Billion | $2.79 Billion | ▲ +115.1% |
| 2014 | 0.39x | $2.75 Billion | $7.06 Billion | $2.75 Billion | ▲ +40.2% |
| 2013 | 0.28x | $2.06 Billion | $7.40 Billion | $2.06 Billion | ▼ -58.2% |
| 2012 | 0.66x | $4.62 Billion | $6.95 Billion | $4.62 Billion | ▲ +300.9% |
| 2011 | 0.17x | $1.30 Billion | $7.82 Billion | $1.30 Billion | ▼ -26.8% |
| 2010 | 0.23x | $2.42 Billion | $10.68 Billion | $2.42 Billion | ▼ -10.0% |
| 2009 | 0.25x | $2.96 Billion | $11.74 Billion | $2.96 Billion | ▼ -45.5% |
| 2008 | 0.46x | $4.04 Billion | $8.74 Billion | $4.04 Billion | ▲ +106.7% |
| 2007 | 0.22x | $1.68 Billion | $7.51 Billion | $1.68 Billion | ▲ +28.4% |
| 2006 | 0.17x | $1.34 Billion | $7.69 Billion | $1.34 Billion | ▲ +19.9% |
| 2005 | 0.15x | $979.00 Million | $6.74 Billion | $979.00 Million | ▲ +113.1% |
| 2004 | 0.07x | $332.00 Million | $4.87 Billion | $332.00 Million | ▼ -81.8% |
| 2003 | 0.38x | $1.28 Billion | $3.42 Billion | $1.28 Billion | ▲ +35.4% |
| 2002 | 0.28x | $1.34 Billion | $4.83 Billion | $1.34 Billion | ▼ -66.8% |
| 2001 | 0.84x | $2.26 Billion | $2.71 Billion | $2.26 Billion | ▲ +33.7% |
| 2000 | 0.63x | $1.46 Billion | $2.34 Billion | $1.46 Billion | ▼ -79.4% |
| 1999 | 3.03x | $2.75 Billion | $908.55 Million | $2.75 Billion | ▲ +215.4% |
| 1998 | 0.96x | $844.88 Million | $879.74 Million | $844.88 Million | ▼ -5.0% |
| 1997 | 1.01x | $755.47 Million | $747.21 Million | $755.47 Million | ▲ +24.7% |
| 1996 | 0.81x | $638.76 Million | $787.75 Million | $638.76 Million | ▲ +10.2% |
| 1995 | 0.74x | $431.11 Million | $585.64 Million | $431.11 Million | ▼ -6.5% |
| 1994 | 0.79x | $492.47 Million | $625.36 Million | $492.47 Million | ▲ +20.0% |
| 1993 | 0.66x | $462.99 Million | $705.58 Million | $462.99 Million | ▼ -66.7% |
| 1992 | 1.97x | $406.47 Million | $206.27 Million | $406.47 Million | ▲ +158.3% |
| 1991 | 0.76x | $385.46 Million | $505.22 Million | $385.46 Million | ▲ +13.9% |
| 1990 | 0.67x | $540.10 Million | $806.30 Million | $540.10 Million | — |